11/04/2026
How cool! Elite fertility and longevity clinics are achieving groundbreaking results by reversing menopause in post-menopausal women. In a trial involving 290 women aged 45 to 62, 97% showed measurable ovarian activity within just 12 weeks. Remarkably, 34 participants achieved natural pregnancies, including one at age 59, demonstrating the potential of this new approach to fertility restoration.
The treatment combines platelet-rich plasma (PRP) with a proprietary mitochondrial activator, directly injected into ovarian tissue. This method reactivates dormant follicles and the hypothalamic-pituitary-ovarian axis, restoring key hormone levels estradiol, progesterone, FSH, and LH to those seen in women in their late 20s.
Beyond fertility benefits, participants reported reduced menopausal symptoms, improved bone density, and enhanced cognitive clarity. These breakthroughs are redefining menopause, transforming it from an unavoidable life stage into a potentially reversible condition with far-reaching health and quality-of-life implications.
Source: Clinical trial reports, advanced fertility research studies
